Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Tertiary Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel BCl3 catalyzed route improves yield and safety for SGLT2 inhibitor manufacturing supply chain reliability and cost efficiency significantly for global buyers.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Solve chiral synthesis challenges with this one-pot two-step method. Achieve 95% ee, 80-89% yield, and simplified production for pharmaceutical intermediates.